Your browser doesn't support javascript.
loading
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
van der Straten, Lina; Stege, Claudia A M; Kersting, Sabina; Nasserinejad, Kazem; Dubois, Julie; Dobber, Johan A; Mellink, Clemens H M; van der Kevie-Kersemaekers, Anne-Marie F; Evers, Ludo M; de Boer, Fransien; Koene, Harry R; Schreurs, John; van der Klift, Marjolein; Velders, Gerjo A; van der Spek, Ellen; van der Straaten, Hanneke M; Hoogendoorn, Mels; van Gelder, Michel; Posthuma, Eduardus F M; Visser, Hein P J; Houtenbos, Ilse; Idink, Cecile A M; Issa, Djamila E; Dompeling, Ellen C; van Zaanen, Henk C T; Veelken, J Hendrik; Levenga, Henriette; Tick, Lidwine W; Terpstra, Wim E; Tonino, Sanne H; Westerweel, Peter E; Langerak, Anton W; Kater, Arnon P; Levin, Mark-David.
Affiliation
  • van der Straten L; Department of Immunology, Erasmus MC, Rotterdam, The Netherlands.
  • Stege CAM; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Kersting S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Nasserinejad K; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam-Treatment and Quality of Life, Amsterdam, The Netherlands.
  • Dubois J; Department of Hematology, HAGA Teaching Hospital, The Hague, The Netherlands.
  • Dobber JA; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Mellink CHM; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • van der Kevie-Kersemaekers AF; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Evers LM; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • de Boer F; Department of Human Genetics, Section Cytogenetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Koene HR; Department of Laboratory Special Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Schreurs J; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands.
  • van der Klift M; Department of Hematology, Antonius Hospital, Nieuwegein, The Netherlands.
  • Velders GA; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.
  • van der Spek E; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
  • van der Straaten HM; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands.
  • Hoogendoorn M; Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands.
  • van Gelder M; Department of Internal Medicine, St Jansdal Hospital, Harderwijk, The Netherlands.
  • Posthuma EFM; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Visser HPJ; Department of Hematology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Houtenbos I; Department of Internal Medicine, Reinier The Graaf Hospital, Delft, The Netherlands.
  • Idink CAM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Issa DE; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.
  • Dompeling EC; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.
  • van Zaanen HCT; Department of Internal Medicine, ZorgSaam Hospital, Terneuzen, The Netherlands.
  • Veelken JH; Department of Internal Medicine, Jeroen Bosch Hospital, s-Hertogenbosch, The Netherlands.
  • Levenga H; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.
  • Tick LW; Department of Internal Medicine, St Franciscus Hospital, Rotterdam, The Netherlands.
  • Terpstra WE; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Tonino SH; Department of Internal Medicine, Groene Hart Hospital, Gouda, The Netherlands.
  • Westerweel PE; Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands.
  • Langerak AW; Department of Internal Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Kater AP; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.
  • Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Blood ; 142(13): 1131-1142, 2023 09 28.
Article in En | MEDLINE | ID: mdl-37363833
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Diagnostic_studies / Prognostic_studies / Qualitative_research Limits: Aged / Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Diagnostic_studies / Prognostic_studies / Qualitative_research Limits: Aged / Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Netherlands